Sign in to continue:

Friday, July 24th, 2026

Jackson Financial Announces CEO Laura Prieskorn’s Retirement; Don Cummings Named Successor in Executive Leadership Transition 1





Jackson Financial Inc. Announces CEO Retirement and Executive Leadership Succession Plan

Jackson Financial Inc. Announces CEO Retirement and Executive Leadership Succession Plan

Key Points from the Report

  • CEO Laura Prieskorn to Retire: Laura Prieskorn, President and CEO of Jackson Financial Inc. (NYSE: JXN), has announced her plans to retire at the end of 2026 after nearly 40 years with the company.
  • Leadership Transition: Don Cummings, current Executive Vice President and Chief Financial Officer, will succeed Prieskorn as President and CEO, and will also join the Board of Directors. This leadership change is effective October 1, 2026.
  • New CFO Appointment: Brian Walta will be promoted to Executive Vice President and Chief Financial Officer, also effective October 1, 2026.
  • Transition Plan: Prieskorn will remain as an advisor through December 31, 2026, to ensure a smooth transition.
  • Strong Management Bench: Both Cummings and Walta have decades of industry experience and are well-respected within the company and the broader financial services sector.
  • Company Stability and Growth: The Board and executive team emphasize continuity, strong company culture, and the execution of Jackson’s growth strategy.
  • Company Background: Jackson Financial Inc. is a major U.S. holding company specializing in retirement planning products and services, with a history of award-winning customer service.
  • Forward-Looking Statements: The company cautions investors that forward-looking statements are subject to risks and uncertainties, and actual outcomes may differ materially from projections.

Details for Investors and Shareholders

Jackson Financial Inc. (JXN) has announced a significant leadership transition that could have material implications for the company and its shareholders. President and CEO Laura Prieskorn will retire at the end of 2026, capping nearly four decades at Jackson, during which she led the company through pivotal moments, including its demerger and period of significant growth. Prieskorn will remain as an advisor through the end of 2026 to support the transition.

The Board of Directors has unanimously appointed Don Cummings, the current Executive Vice President and Chief Financial Officer, as her successor. Cummings will take over as President and CEO and join the Board of Directors on October 1, 2026. Cummings has more than 30 years of industry experience, having joined Jackson in 2020 as Chief Accounting Officer and Controller and later promoted to CFO in 2024. His prior roles include interim CFO at Fortitude Reinsurance Company and Global Corporate Controller at American International Group, Inc.

In parallel, Brian Walta, a Jackson veteran since 1997 who has held various leadership roles in financial and business functions, will be promoted to Executive Vice President and Chief Financial Officer on October 1, 2026. Walta is a Chartered Financial Analyst, Fellow of the Society of Actuaries, and member of the American Academy of Actuaries.

Investor Takeaways & Potential Share Price Impact

  • Leadership Stability: The company is pursuing an internal succession plan, which signals stability and confidence in its current strategic direction. Both incoming CEO Don Cummings and incoming CFO Brian Walta are seasoned executives with deep knowledge of the company, which may reassure investors about continuity of management and ongoing execution of strategic plans.
  • Growth Strategy Continuity: The Board’s comments and the statements from Cummings and Walta emphasize a commitment to Jackson’s current growth strategy. This suggests there will not be abrupt shifts in business direction, which is typically viewed favorably by the market.
  • Transition Planning: Prieskorn’s continued involvement as an advisor through year-end 2026 is designed to ensure a seamless transition and maintain operational momentum, reducing the risk of disruption.
  • Potential Risks: While the transition appears well-planned, any leadership change at the CEO and CFO level inherently carries some execution risk, particularly as Jackson continues to pursue its growth and innovation agenda.
  • Forward-Looking Statements: The company has highlighted that forward-looking statements are subject to risks and uncertainties, including those disclosed in their most recent SEC filings. Investors should monitor for updates and further disclosures as the transition date approaches.

About Jackson Financial Inc.

Jackson Financial Inc. (NYSE: JXN) is a leading provider of retirement planning solutions in the United States, offering a broad range of annuity products and financial planning resources. The company is recognized for its award-winning customer service and its efforts to simplify the complexities of retirement planning for both financial professionals and their clients.

Jackson operates through several subsidiaries, including Jackson National Life Insurance Company, Brooke Life Insurance Company, P America, Inc., and Jackson National Asset Management LLC. The company is committed to serving a broad range of stakeholders, with a balanced, long-term approach to growth and value creation.

Additional Investor Information

The company encourages investors to monitor its investor relations website and other official communications for material updates. Jackson Financial Inc. may use its website and executive social media channels to disclose important information to the public.

Contact Information

Disclaimer

This article is intended for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any security. All forward-looking statements are subject to risks and uncertainties, and actual results may differ materially. Investors should review the company’s SEC filings and consult their financial advisor before making investment decisions.




View Jackson Financial Inc. Historical chart here



PAVmed Inc. 2025 Annual Report: Financials, Risk Factors, and Corporate Governance Overview

PAVmed Inc. 2025 Annual Report: Key Investor Insights PA...

NRx Pharmaceuticals Selected by DARPA for Innovative SPARC-TMS Clinical Trial to Treat Depression

NRX Pharmaceuticals, Inc. Announces Incorporation of NRx Def...

Hewlett Packard Enterprise Company 8-K SEC Filing Cover Page and XBRL Data for May 13, 2026

Hewlett Packard Enterprise Co (HPE) 8-K Report Analysis – Ma...